Navigation Links
Sequenom Announces Launch of SensiGene Fetal(XY) (Fetal Sex Determination) Test
Date:2/16/2010

val).

More information on the SensiGene test and fetal sex determination can be found at http://www.scmmlab.com/Home/Health-Care-Professionals/Fetal-Sex-Determination.

Sequenom supports the ACOG Committee Opinion, No. 360. Obstet Gynecol 109: 475-478.

About MassARRAY Technology

Sequenom's proprietary MassARRAY® system is a high performance matrix assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry-based nucleic acid analysis platform that quantitatively measures genetic target material and its variations in a rapid, accurate, and cost efficient manner. Sequenom's MassARRAY system facilitates a number of nucleic acid analysis applications including SNP genotyping and allelotyping, CNV analysis, quantitative gene expression analysis, quantitative methylation marker analysis, comparative sequence analysis of haploid organisms, SNP discovery, and oligonucleotide quality control.

About Sequenom Center for Molecular Medicine

Sequenom Center for Molecular Medicine® (Sequenom CMM), a CAP accredited and CLIA-certified molecular diagnostics laboratory, is developing a full range of advanced prenatal diagnostics. Branded under the name SensiGene™, these genetic tests provide earlier patient management alternatives for obstetricians, geneticists and maternal fetal medicine specialists. Sequenom CMM is changing the landscape in genetic disorder diagnostics using proprietary cutting edge technologies. Visit http://

SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. University of Michigan Study Shows SEQUENOMs MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
2. Sequenom Announces Paul Maier to Become Interim Chief Financial Officer
3. Sequenom Announces Addition to Clinical Advisory Board
4. Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit
5. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
6. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
7. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
8. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
9. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
10. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
11. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... 02, 2015 Research and Markets  ( http://www.researchandmarkets.com/research/dg23tb/global ... Pharmaceutical Packaging Market 2015-2019" report to their offering. ... at a CAGR of 5.9% over the period 2014-2019. ... market is the rise in demand for vials and ... second highest growth among all the segments at a ...
(Date:6/3/2015)... , June 3, 2015  VA North Texas ... the successful patient implant of vBloc, a technology-based, scientifically advanced ... a pacemaker-like implant called the Maestro® Rechargeable System ... transmission of messages involving food intake and processing ... is wireless and customizable to meet the needs ...
(Date:6/3/2015)... June 3, 2015 RXi Pharmaceuticals ... company focused on discovering and developing innovative ... and ophthalmology, today announced that it received a ... Patent and Trademark Office (USPTO) on its ... titled "RNA Interference in Ocular Indications," covers ...
Breaking Medicine Technology:Global Pharmaceutical Packaging Market 2015-2019 with Amcor, Bemis Healthcare Packaging, Gerresheimer, MeadWestvaco, Owens-Illinois & West Pharmaceutical Services Dominating 2VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 2VA North Texas First VA in the Country to Perform vBloc Implant, a Cutting-Edge Weight Loss Therapy 3RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 2RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 3RXi Pharmaceuticals Granted Notice of Allowance for Patent Covering Lead Compound, RXI-109, for Use in the Eye 4
... AG (,Intercell,) to acquire Iomai Corporation (,Iomai,) in ... per share of Iomai,s common stock ... of approximately USD 189 million (EUR ... exchange for approximately 41 percent of Iomai,s ...
... The Alliance for Lupus,Research (ALR) commends the Senate ... ideals of National Women,s Health Week that begins,annually on ... and Olympia Snowe (R-ME) calls on all Americans to ... an opportunity to educate themselves on,women,s health issues, and ...
Cached Medicine Technology:Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 2Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 3Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 4Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 6Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 7Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 8Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 9Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 10Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 11Lupus Under the Spotlight: U.S. Congress Shows Support for Women's Health Issues 2
(Date:6/3/2015)... (PRWEB) June 03, 2015 Researchers at ... biomarkers for mesothelioma and say the tried-and-true marker mesothelin ... posted an article on the research. Click here ... University’s National Center for Asbestos Related Diseases say, even ... results, it is still preferable to fibulin-3 for identifying ...
(Date:6/3/2015)... Sitting at a computer for hours on ... neck, shoulders and/or wrists. This can lead to a ... research links sitting for long periods as a risk ... inventors from Oakville, Ontario, are offering an option to ... have developed a prototype for a patent-pending device to ...
(Date:6/3/2015)... June 03, 2015 On Sunday, June ... world will gather in their local communities to observe ... cities across the U.S. and abroad will hold celebrations ... attention to the ongoing challenges of cancer survivorship, and ... diagnosis can be fruitful, rewarding, and inspiring.,  , National ...
(Date:6/3/2015)... Fourroux Prosthetics, located at 6630 McGinnis Ferry Rd, ... opening with a ribbon cutting ceremony on Wednesday, June ... kind in the area, Fourroux Prosthetics will provide amputee ... use of patented advanced prosthetics CAD/CAM technology. ... states, “Our goal has always been to provide amputees ...
(Date:6/3/2015)... June 03, 2015 These are challenging ... The ever growing number of digital-first business are rewriting ... is now a serious need for traditional businesses to ... they operate and deliver their services. On top ... between incumbents and technology start-ups, to bring new innovation ...
Breaking Medicine News(10 mins):Health News:Analysis Reveals Gold Standard Mesothelioma Biomarker Still the Best, According to Surviving Mesothelioma 2Health News:Adjustable Height Tabletop Unit Invented by Three InventHelp® Clients (TOR-9278) 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 2Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 3Health News:Communities to Recognize Cancer Survivors, Raise Awareness on National Cancer Survivors Day® – Sunday, June 7 4Health News:Fourroux Prosthetics Atlanta to Have Grand Opening Gala & Ribbon Cutting Ceremony 2Health News:Chief Digital Officer of Travelex joins Bayer, Abellio and Just Eat at The Open Mobile Summit London 2
... ... Months, CHICAGO, April ... that,physicians use to improve healthcare, announced today that it will report,its earnings ... on Wednesday, April 30, 2008. At 4:30 PM Eastern Daylight,Time on the ...
... Combining a herpes virus genetically altered to express a ... reduced the size of highly malignant human sarcoma grafted ... growing arsenal of so called oncolytic viruses under development ... according to a research led by Cincinnati Childrens Hospital ...
... Technologies(R),Inc. (OTC Bulletin Board: GLOB), an international e-Health, ... and CEO,Michael I. Ruxin, M.D., will be presenting ... conference at the Omni Los Angeles hotel on ... http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO ), "It is truly gratifying ...
... Nearly Three-Quarters of Physicians Have Switched Patients to ... According to a New Report from Decision Resources, ... one of the,world,s leading research and advisory firms ... of primary care physicians,(PCPs) and endocrinologists who consider ...
... Primary care clinicians need,to focus on three key ... status, and anemia. Clinicians, in tandem with ob/gyns,and ... awareness about,women,s health requirements and to provide optimum ... healthcare providers, The Journal of Family,Practice and OBG ...
... about the size of a pencil eraser are more likely to ... according to a new study led by NYU Langone Medical Center ... published in the April issue of Archives of Dermatology, the NYU ... that are larger than 6 millimeters, the size of a pencil ...
Cached Medicine News:Health News:Allscripts to Announce First Quarter 2008 Results on April 30 2Health News:Allscripts to Announce First Quarter 2008 Results on April 30 3Health News:Potential viral therapy weapon for difficult cancers is safe and effective in study 2Health News:Potential viral therapy weapon for difficult cancers is safe and effective in study 3Health News:Potential viral therapy weapon for difficult cancers is safe and effective in study 4Health News:Global Med Technologies(R), Inc. to Present at Inaugural LD MICRO Conference at the Omni Hotel in Los Angeles 2Health News:Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKline's Avandia Increases Nine-Fold Following Publication of Meta-Analysis 2Health News:Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKline's Avandia Increases Nine-Fold Following Publication of Meta-Analysis 3Health News:The Women's Health II Medical Education Network Raises Awareness About the Diagnosis and Management of Women's Health Issues 2Health News:Melanoma lurks in larger skin lesions, NYU researchers find 2
The Auto Suture™ EEA™ reusable stainless steel sizer set has application in intestinal, colorectal and esophageal surgery to help evaluate the diameter of tubular structures....
Fully automated Chemiluminescence assay for the measurement of calcitonin hormone in serum....
Validated by decades of research and clinical experience, HFA is the accepted standard of care in glaucoma diagnosis and management. With HFA you can feel confident you're providing the best possible...
... One complete solution. , Increased requirements for ... turnover. These are just some of the ... that can impact the amount of time ... , , You can't afford to ...
Medicine Products: